Skip to main content
OpenTrials

Clinical trial condition

Multiple Myeloma

Explore clinical trials studying Multiple Myeloma. Study availability and eligibility vary by location and protocol.

2,610 public trials 494 recruiting studies
Refine in advanced search Browse all conditions

Multiple Myeloma trial results

Completed

A Study of an Accelerated Infusion Rate of Daratumumab in Patients With Relapsed and Refractory Multiple Myeloma

NCT03697629

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations
  • Kingston Health Sciences Centre Kingston, Ontario, Canada
  • Princess Margaret Cancer Centre Toronto, Ontario, Canada
  • Hôpital Maisonneuve-Rosemont Montreal, Quebec, Canada
  • McGill University Health Centre Montreal, Quebec, Canada
View Trial Details
Completed

Study of Single Agent CJM112, and PDR001 in Combination With LCL161 or CJM112 in Patients With Multiple Myeloma

NCT03111992

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
  • Novartis Investigative Site Freiburg im Breisgau, Germany
  • Novartis Investigative Site Heidelberg, Germany
View Trial Details
Completed

Study of the Combination of Panobinostat and Carfilzomib in Patients With Relapsed/Refractory Multiple Myeloma

NCT01496118

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Florida Cancer Specialists South Fort Myers, Florida, United States
  • Woodlands Medical Specialists Pensacola, Florida, United States
  • Florida Cancer Specialists North St. Petersburg, Florida, United States
View all 13 locations
View Trial Details
Completed

Optimising Renal Outcome in Myeloma Renal Failure

NCT02424851

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +25 more
Locations
  • Basingstoke & North Hampshire Hospital Basingstoke, United Kingdom
  • Heartlands Hospitals Birmingham, United Kingdom
  • Kent & Canterbury Hospital Canterbury, United Kingdom
  • St Helier Hospital Epsom, United Kingdom
View Trial Details
Completed

Carfilzomib in Combination With Daratumumab, Lenalidomide and Dexamethasone in Transplant-ineligible NDMM Patients

NCT04065789

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations
  • Haemek Medical Center Afula, Israel
  • Barzilai Medical Center Ashkelon, Israel
  • Soroka Medical Center Beersheba, Israel
  • Bnai-Zion Medical Center Haifa, Israel
View all 14 locations
View Trial Details
Completed

Evaluation of Safety of Pomalidomide in Combination With Dexamethasone (Low Dose) in Patients With Refractory or Relapsed and Refractory Multiple Myeloma

NCT01712789

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • Medical University of Graz Graz, Austria
  • Medizinische Universitat Innsbruck Innsbruck, Austria
  • Wilhelminenspital Vienna Vienna, Austria
  • Medical University of Vienna Vienna, Austria
View all 112 locations
View Trial Details

Related conditions